Pentagon issues new guidance for testosterone testing after rescinding previous one

Pentagon issues new guidance for testosterone testing

Provpnadvice.com – The Pentagon issues new guidance for testosterone testing among male active-duty service members and reservists after briefly withdrawing an earlier policy. The updated instructions establish a standardized process for identifying and treating testosterone deficiency across the Defense Health Agency.

Officials described the policy as part of a wider military-readiness effort focused on health, resilience and performance. The department said it is investing in the well-being of warfighters while seeking to maintain a force prepared for combat.

“By proactively identifying and treating suboptimal hormone levels, the Department continues to invest in the health of its warfighters, strengthen their performance and maximize force readiness,” Pentagon chief spokesperson Sean Parnell said.

Who may receive testosterone screening

Male service members older than 30 will receive a structured review of symptoms and potential risk factors. Personnel under 30 may be screened when they request testing or when a medical provider determines there is a clinical reason to order it.

Providers must document symptoms and risk factors so assessments are more consistent throughout the military health system. The symptom review includes erectile dysfunction, reduced sexual desire, muscle loss, increased body fat, depressed mood, low motivation, sleep issues, difficulty concentrating, memory problems and unexplained declines in endurance or physical performance.

The Defense Health Agency said reduced sexual desire, erectile dysfunction and loss of spontaneous morning erections are the symptoms most specifically associated with androgen deficiency. Other symptoms may also result from inadequate sleep, insufficient energy intake, mood disorders or overtraining.

“The combination of reduced sexual desire, loss of spontaneous morning erections, and erectile dysfunction have been shown to be most specific for androgen deficiency,” the DHA said in its guidance.

Risk factors and testing requirements

The Pentagon issues new guidance for testosterone assessment that also directs clinicians to consider relevant medical history. Factors include obesity, Type 2 diabetes, metabolic syndrome, long-term opioid or glucocorticoid use, traumatic brain injury with loss of consciousness, testicular trauma, testicular torsion, orchitis and suspected or diagnosed obstructive sleep apnea.

Providers may also review a history of undescended testis, chemotherapy, pelvic radiation, low-trauma fractures, repeated bone stress injuries, unexplained anemia, infertility and gynecomastia. A diagnosis cannot be confirmed from a single laboratory result; a second test is required on a different day under the same pre-test conditions.

Testing generally should occur from 7 a.m. to 10 a.m. For personnel working night or rotating shifts, blood should be drawn within three hours of waking after a full night of sleep. Service members are expected to be fasting, and testing should not take place within 30 days of recovery from an illness.

Treatment and deployment considerations

When testosterone replacement therapy is appropriate, clinicians will consider the service member’s preferences, convenience, ability to follow the treatment plan, product selection and dosage. The guidance identifies testosterone cypionate and testosterone enanthate as injectable options that may be given subcutaneously or intramuscularly.

The starting dose may be 100 milligrams once a week, or the weekly amount may be divided into two doses. Personnel may begin treatment within 90 days before deployment. Continuing therapy during deployment requires an assessment four to six weeks after treatment begins, showing clinical stability and testosterone levels within the target range of 300 to 600 ng/dL.

FAQ: Pentagon testosterone testing guidance

Does every male service member receive a testosterone test?

No. The guidance calls for a structured symptom and risk-factor review for men older than 30. Younger personnel may be screened upon request or when a provider finds a clinical reason for testing.

Can one low result confirm testosterone deficiency?

No. The policy requires a second test on a separate day under the same pre-test conditions before deficiency is confirmed.

Can service members deploy while receiving treatment?

They may continue therapy during deployment when they meet the required stability review and have testosterone levels in the stated target range.